Perbedaan Brigit Biofarmaka Teknologi Tbk. dan J Resources Asia Pasifik Tbk.: Brigit Biofarmaka Teknologi Tbk. diperdagangkan di Rp240 (kapitalisasi pasar 166,01 M, volume 24 jam 324 rb), sedangkan J Resources Asia Pasifik Tbk. diperdagangkan di Rp580 (kapitalisasi pasar 15,48 T, volume 24 jam 68,06 jt). Perbedaan utamanya: J Resources Asia Pasifik Tbk. jauh lebih besar — sekitar 93,2× kapitalisasi pasar Brigit Biofarmaka Teknologi Tbk., dan J Resources Asia Pasifik Tbk. lebih aktif diperdagangkan (68,06 jt vs 324 rb). Mana yang lebih baik tergantung tujuan investasimu.
| OBAT | PSAB | |
|---|---|---|
Kapitalisasi Pasar | 166,01 M | 15,48 T |
Volume | 324 rb | 68,06 jt |
Lot | 3,24 rb | 680,58 rb |
Perputaran | 77,68 jt | 39,21 M |
Harga Rata-rata | 239,75 | 576,11 |
Nilai Transaksi | 77,68 jt | 39,21 M |
Harga Ekuilibrium Indikatif | 240 | 580 |
Volume Ekuilibrium Indikatif | 1 | 21,68 rb |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Selengkapnya di halaman OBAT →PT J Resources Asia Pasifik Tbk (the Company) was established under the name of PT Pelita Sejahtera Abadi Tbk on January 14, 2002. PT Pelita Sejahtera Abadi Tbk is an Indonesia-based service company. The Company operates food courts and provides catering services. In addition, it is engaged in the transportation, telecommunication and real estate sectors. The Company is headquartered in Semarang, Indonesia.
Selengkapnya di halaman PSAB →